Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...

The first command center for scientific AI, bringing agents and models to every scientist SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- Benchling AI launches today, giving scientists a command center to ...

After picking up $200 million just over six months ago, Benchling isn’t sitting still. The cloud-based R&D platform developer collected another $100 million to help power its global expansion plans.

Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...

Nearly half (44%) of top 50 biopharma companies are now involved in RNA work sparking new demand for tools purpose built for the full spectrum of RNA R&D SAN FRANCISCO, Sept. 7, 2022 /PRNewswire/ -- ...

After collecting $300 million across two venture capital rounds last year, R&D cloud software developer Benchling is starting to spend some of that cash by making its first acquisition. The company ...

On Thursday, San Francisco-based R&D cloud software company Benchling announced that it has acquired Belfast-based Ovewatch Research, a software company for customers working on preclinical biopharma ...

Ten years ago, Sajith Wickramasekara dropped out of the Computer Science program at MIT to build something new: a software company that helps life science researchers better organize their lab work.

In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like Benchling, which provides software for managing life sciences research, was able to nab ...

Email and a smarter notebook might be enough for handling communication for projects or experiments inside a team in a lab in some university basement. But when you have around 200 scientists working ...

Nearly half (44%) of top 50 biopharma companies are now involved in RNA work sparking new demand for tools purpose built for the full spectrum of RNA R&D Following the successful deployment of RNA ...